Testing effectiveness (Phase 2)Study completedNCT02304315
What this trial is testing
GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients
Who this might be right for
Hepatitis B Infection
Green Cross Corporation 40